HOME >> MEDICINE >> NEWS
NIAID launches first Phase II trial of a 'global' HIV/AIDS vaccine

A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today. The study investigators plan to enroll a total of 480 participants at sites in Africa, North America, South America and the Caribbean to test the safety and immune response to the vaccine.

The experimental vaccine was developed by scientists at NIAID's Dale and Betty Bumpers Vaccine Research Center (VRC) and is being studied in the HIV Vaccine Trials Network (HVTN), a clinical research collaboration funded by NIAID's Division of AIDS (DAIDS).

"This trial marks an important step in the advancement toward an AIDS vaccine. The rapid development of this candidate vaccine--less than five years since the launch of the VRC--underscores our commitment to hasten the day when we have an effective AIDS vaccine," says NIAID Director Anthony S. Fauci, M.D.

The unique vaccine combines synthetically modified elements of four HIV genes found in subtypes A, B and C of the virus--the subtypes commonly found in Africa, the Americas, Europe and parts of Asia. These subtypes represent about 85 percent of HIV infections worldwide.

"This is the first Phase II study of a vaccine candidate that is broadly relevant to the global AIDS pandemic because it combines components of HIV strains found throughout the world," says VRC Director Gary Nabel, M.D., Ph.D. "We look forward to working with our partners in the United States and abroad as we take this vaccine into the next phase of clinical evaluation."

The trial, known as HVTN 204, is being coordinated with two other planned clinical studies, an unprecedented collaboration among researchers in three clinical trial networks and NIAID. The International AIDS Vaccine Initiative plans to conduct a Phase I study of the VRC vaccine at sites in Kenya and Rwand
'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
11-Oct-2005


Page: 1 2 3 4

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
7. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
8. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
9. NIAID media availability: Understanding influenza infection
10. NIAID researchers show how promising TB drug works
11. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/13/2019)... ... 2019 , ... cbdMD, Inc., a nationally recognized consumer cannabidiol ... Brightfield Group, a leading cannabis research firm. In their recent mid-year 2019 Market ... in two categories, Topicals and Skincare/Beauty. , "There is a massive shakeup in ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... 1 the expansion of its territory through the acquisition of another Houston-area distributor. ... region to include three facilities located in LaPorte, Nederland and Houston. , ...
(Date:7/10/2019)... ... ... HMP, a leader in healthcare events and education, today announced the Community ... place October 11-13, 2019 in Boston. , Launched in 2016, the Congress is the ... clinical pathways as a decision support tool and their increasing influence on patient care. ...
(Date:7/9/2019)... (PRWEB) , ... July 09, 2019 , ... Human cytomegalovirus ... to Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half of the ... dormant in your body for the rest of your life and can flare up ...
(Date:7/9/2019)... ... July 09, 2019 , ... Smile ... support services to more than 400 affiliated offices across 17 states, is pleased ... , Smile Brands will provide full-service administrative support to the practice, including; purchasing, ...
Breaking Medicine News(10 mins):
(Date:7/11/2019)... Tenn. (PRWEB) , ... July 11, 2019 , ... ... announced the addition of Jaylee Hilliard, MSN, RN, NEA-BC, as a clinical advisor. ... Health. She joins the AngelEye Health team with more than a decade of ...
(Date:7/11/2019)... PHILADELPHIA (PRWEB) , ... July 11, 2019 , ... ... from hemp, has recently created products in line with TSA guidelines for domestic ... In May 2019, the TSA changed its guidelines to allow some ...
(Date:7/11/2019)... ... July 11, 2019 , ... Nobility RCM, ... partnership with Palmer College of Chiropractic, the first and largest chiropractic college in ... specially selected to handle its billing and revenue cycle for the institution’s clinical ...
Breaking Medicine Technology:
Cached News: